Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Clinical Transplantation|November 8, 2024
Novel Scoring System for Ranking Hematopoietic Stem Cell TransplantationLee Ann Baxter-Lowe, Tao Wang, Michelle Kuxhausen, et al.
Pediatric Blood & Cancer|October 7, 2020
Phase 1 study of pomalidomide in children with recurrent, refractory, and progressive central nervous system tumors: A Pediatric Brain Tumor Consortium trialJason Fangusaro, Duane A Mitchell, Mehmet Kocak, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|September 28, 2010
Single-nucleotide polymorphisms in the β-adrenergic receptor genes are associated with lung allograft utilizationAnil Sapru, Ludmila Pawlikowska, Kathleen D Liu, et al.
Blood|August 30, 2008
Results of the Cord Blood Transplantation Study (COBLT): clinical outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with hematologic malignanciesJoanne Kurtzberg, Vinod K Prasad, Shelly L Carter, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 3, 2010
Reduced-intensity conditioning allogeneic hematopoietic cell transplantation for patients with hematologic malignancies who relapse following autologous transplantation: a multi-institutional prospective study from the Cancer and Leukemia Group B (CALGB trial 100002)Asad Bashey, Kouros Owzar, Jeffrey L Johnson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 21, 2012
Transplantation-related mortality, graft failure, and survival after reduced-toxicity conditioning and allogeneic hematopoietic stem cell transplantation in 100 consecutive pediatric recipientsPrakash Satwani, Zhezhen Jin, Deirdre Duffy, et al.
Pediatric Blood & Cancer|March 14, 2014
Pilot trial of risk-adapted cyclophosphamide intensity based conditioning and HLA matched sibling and unrelated cord blood stem cell transplantation in newly diagnosed pediatric and adolescent recipients with acquired severe aplastic anemiaCatherine McGuinn, Mark B Geyer, Zhezhen Jin, et al.
British Journal of Haematology|October 28, 2008
Infusion of haplo-identical killer immunoglobulin-like receptor ligand mismatched NK cells for relapsed myeloma in the setting of autologous stem cell transplantationJumei Shi, Guido Tricot, Susann Szmania, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 20, 2016
A Phase I Study of Reduced-Intensity Conditioning and Allogeneic Stem Cell Transplantation Followed by Dose Escalation of Targeted Consolidation Immunotherapy with Gemtuzumab Ozogamicin in Children and Adolescents with CD33+ Acute Myeloid LeukemiaStacey Zahler, Monica Bhatia, Angela Ricci, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 15, 2011
A Phase I study of gemtuzumab ozogamicin (GO) in combination with busulfan and cyclophosphamide (Bu/Cy) and allogeneic stem cell transplantation in children with poor-risk CD33+ AML: a new targeted immunochemotherapy myeloablative conditioning (MAC) regimenPrakash Satwani, Monica Bhatia, James H Garvin, et al.
Pageof 5